Serum pentraxin 3 as a biomarker for prognosis of acute minor stroke due to large artery atherosclerosis.

Brain and Behavior
Yan ZhangTingting Zhao

Abstract

Pentraxin 3 (PTX3) may reflect local inflammatory status in tissues and thus serve as a potential biomarker of inflammation. Here, we investigated the utility of serum PTX3 as an index for assessing the 90-day prognosis of acute minor stroke patients. Acute minor stroke patients (N = 241) and matched healthy control subjects (N = 241) were prospectively recruited. Clinical, laboratory, and imaging data were assessed. Blood samples were collected within 48h after acute minor stroke onset and serum PTX3 levels were determined. Significant increases in stroke patients versus controls were obtained for serum PTX3 (3.14 ± 1.23 vs. 2.44 ± 0.74 ng/ml; p < .001) and C-reactive protein (CRP - 1.53 ± 0.38 vs. 1.35 ± 0.35 μg/ml; p < .05). Among the four stroke subtypes, as defined by modified Trial of Org 10172 in Acute Stroke Treatment classification, there were no statistically significant differences in serum PTX3 levels (p > .05). Multivariate logistic regression analysis revealed that serum PTX3 and LDL cholesterol could predict unfavorable outcomes at day 90 in Large Artery Atherosclerosis (LAA) patients. Serum Pentraxin 3 may serve as an independent predictor for an unfavorable outcome in the LAA subtype of acute minor stroke and m...Continue Reading

References

Jul 1, 1989·Stroke; a Journal of Cerebral Circulation·T BrottV Hertzberg
May 1, 1988·Stroke; a Journal of Cerebral Circulation·J C van SwietenJ van Gijn
Mar 18, 2005·Annual Review of Immunology·Cecilia GarlandaAlberto Mantovani
Jan 26, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Giuseppe Danilo NorataAlberico Luigi Catapano
Sep 5, 2009·Journal of Atherosclerosis and Thrombosis·Hiroyuki OhbayashiRyouichi Onda
Feb 27, 2010·Stroke; a Journal of Cerebral Circulation·Urs FischerHeinrich P Mattle
Dec 20, 2011·Atherosclerosis·Wi-Sun RyuByung-Woo Yoon
Aug 17, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Peter Libby
Dec 19, 2012·Diabetes Research and Clinical Practice·Naoto KatakamiIichiro Shimomura
Jun 28, 2013·The New England Journal of Medicine·Yongjun WangUNKNOWN CHANCE Investigators
Mar 19, 2014·Journal of Thrombosis and Haemostasis : JTH·N S JennyB M Psaty
Jan 7, 2015·Turkish Journal of Medical Sciences·Sevilay SezerHaci Kemal Erdemli
Mar 15, 2016·International Heart Journal·Takeshi Soeki, Masataka Sata
Oct 21, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Josef Anrather, Costantino Iadecola
Jan 14, 2016·Biochemistry and Biophysics Reports·Aya ShirakiKoichi Node
Oct 21, 2017·Vascular Pharmacology·Matteo CasulaFederico Carbone
Jun 28, 2018·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Chun-Yang ZhangBen-Qiang Deng
Jul 30, 2018·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Claudia-Alexandrina IrimieDan-Ioan Minea
Sep 18, 2018·Brain and Behavior·Andrej Netland KhanevskiChristopher E Kvistad
Oct 14, 2018·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Ivana RajkovicEmmanuel Pinteaux
Jun 14, 2019·Frontiers in Immunology·Giuseppe A RamirezEnrico Tombetti

❮ Previous
Next ❯

Software Mentioned

SPSS
TOAST

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Arteriosclerosis, Thrombosis, and Vascular Biology
Michael S RolphGöran K Hansson
International Journal of Vascular Medicine
Kenji InoueHiroyuki Daida
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
I NinomiyaO Onodera
© 2021 Meta ULC. All rights reserved